Adjuncts or Just Fluid: Treating Rhabdomyolysis-Associated AKI
A single patient found down after an eighteen-hour fall with a markedly elevated creatine kinase. The disagreement is whether adding bicarbonate and mannitol to her fluid resuscitation actually protects her kidneys beyond what aggressive isotonic fluid alone already does.
V.T., an 82-year-old widow who has lived alone in her own home for the six years since her husband died, was found on her kitchen floor by a neighbor who noticed her newspapers piling up — roughly eighteen hours after she says she slipped reaching for a cabinet and could not get back up. She is alert and oriented, mortified more than anything by the whole episode, and by her own account had been trying periodically to call for help before her phone battery died. She has no history of falls before this one, still drives to her own grocery store twice a week, and has no cognitive impairment on today's bedside exam — a genuinely independent 82-year-old whose injury tonight is entirely mechanical, not the start of a broader decline. Prolonged immobilization on a hard floor for that many hours is, on its own, enough to cause the finding that is now driving her care: her creatine kinase, drawn in the emergency department, is 42,000 U/L, and her creatinine has already risen to 2.1 mg/dL from a normal outpatient baseline confirmed on a lab from six months ago.
Aggressive isotonic fluid resuscitation is not in dispute — every voice at her bedside agrees she needs large-volume crystalloid, both to correct the volume depletion from eighteen hours without oral intake and to increase renal blood flow and urine flow rate, diluting the myoglobin concentration reaching her tubules and mechanically flushing forming casts before they obstruct. What is actually contested is whether adding sodium bicarbonate, to alkalinize her urine and reduce myoglobin's tendency to precipitate into casts at acidic pH, or mannitol, to promote an osmotic diuresis on top of volume-driven flow, meaningfully improves on fluids alone. The literature here is thinner and older than for many other AKI-prevention questions a team might face — the most-cited retrospective series, from Brown et al., examined trauma patients with severe rhabdomyolysis and found no significant difference in renal failure, dialysis requirement, or mortality between those who received bicarbonate and mannitol and those who received aggressive isotonic fluids alone, though the study was retrospective and not powered to detect a modest benefit if one existed.
Emergency department, deciding what goes in the fluid
I want aggressive isotonic saline running now, and I do not think we need to overthink the rest of the regimen beyond that. The retrospective literature on bicarbonate and mannitol in rhabdomyolysis — the Brown series is the one most people cite — found no significant difference in renal failure or dialysis need between patients who got the adjuncts and those who got fluids alone. Fluid volume and rate are the part of this we actually have reasonable evidence for.
I agree the fluid-alone data are reasonably solid, and I am not going to argue for mannitol — an osmotic diuretic in an 82-year-old who is not yet fully volume-resuscitated carries a real risk of worsening intravascular depletion before it helps anything, and I do not think the modest theoretical benefit is worth that in a patient her age. Bicarbonate I am more genuinely torn on: the Brown series found no benefit, but it was retrospective, not powered to detect anything short of a large effect, and the mechanistic case for urine alkalinization reducing myoglobin cast formation at the tubular level is not unreasonable on its own.
I want to be honest that my hesitation on bicarbonate is closer to genuine uncertainty than to a confident recommendation either way — the evidence simply is not strong enough to be more decisive than that.
I hear that, and I am not going to insist the question is fully closed — only that the burden of proof for adding a second intervention on top of a treatment that already works reasonably well should be higher than a retrospective negative study with genuine uncertainty attached. Given her age and the added complexity of monitoring urine pH and adjusting a bicarbonate drip, I would rather keep her regimen simple: aggressive isotonic fluid, reassess her trajectory, and add nothing else unless her renal function fails to improve as expected.
The nephrologist's own uncertainty is itself the strongest argument for simplicity here, not for adding the adjunct — genuine equipoise favors the simpler regimen when the more complex one has no confirmed benefit to offer in exchange.
Agreed: aggressive isotonic saline resuscitation alone, with hourly urine output and serial creatinine and CK monitoring, and no bicarbonate or mannitol added.
The nephrologist's genuine uncertainty about bicarbonate was recorded rather than resolved into a confident negative — both physicians agreed the decision to omit it rested on the added complexity outweighing an unconfirmed benefit, not on a settled judgment that it does not work.